Werewolf Therapeutics (HOWL)
NASDAQ:HOWL
US Market
Holding HOWL?
Track your performance easily

Werewolf Therapeutics (HOWL) Financial Statements

173 Followers

Werewolf Therapeutics Financial Overview

Werewolf Therapeutics's market cap is currently ―. The company's EPS TTM is $-1.346; its P/E ratio is -1.65; Werewolf Therapeutics is scheduled to report earnings on November 7, 2024, and the estimated EPS forecast is $-0.41. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue--$ 5.90M-$ 400.00K
Gross Profit----$ 400.00K
EBIT$ -16.45M$ -15.19M$ -8.29M$ -5.10M$ -13.29M
EBITDA$ -15.83M$ -14.35M$ -7.30M-$ -12.47M
Net Income Common Stockholders$ -16.11M$ -16.19M$ -8.29M$ -5.10M$ -11.95M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 135.30M$ 139.20M$ 130.06M$ 137.45M$ 147.87M
Total Assets$ 153.70M$ 177.60M$ 176.39M$ 185.24M$ 195.07M
Total Debt$ 36.68M$ 51.27M$ 52.19M$ 52.82M$ 53.25M
Net Debt$ -98.62M$ -87.93M$ -77.87M$ -84.64M$ -94.62M
Total Liabilities$ 49.69M$ 60.01M$ 63.94M$ 66.65M$ 74.00M
Stockholders Equity$ 104.02M$ 117.59M$ 112.44M$ 118.60M$ 121.07M
Cash Flow-
Free Cash Flow$ -14.19M$ -15.41M$ -7.43M-$ -10.07M
Operating Cash Flow$ -14.18M$ -15.30M$ -7.21M-$ -9.90M
Investing Cash Flow$ -17.00K$ -111.00K$ -221.00K-$ -168.00K
Financing Cash Flow$ -9.72M$ 20.26M$ 41.00K-$ 48.62M
Currency in USD

Werewolf Therapeutics Earnings and Revenue History

Werewolf Therapeutics Debt to Assets

Werewolf Therapeutics Cash Flow

Werewolf Therapeutics Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis